Cargando…

Considering Personalized Interferon Beta Therapy for COVID-19

Detalles Bibliográficos
Autores principales:	Dorgham, Karim, Neumann, Avidan U., Decavele, Maxens, Luyt, Charles-Edouard, Yssel, Hans, Gorochov, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097459/ https://www.ncbi.nlm.nih.gov/pubmed/33558300 http://dx.doi.org/10.1128/AAC.00065-21

Ejemplares similares

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
por: Davoudi-Monfared, Effat, et al.
Publicado: (2021)

Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies
por: Dorgham, Karim, et al.
Publicado: (2016)

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
por: de Prost, Nicolas, et al.
Publicado: (2021)

Distinct cytokine profiles associated with COVID-19 severity and mortality
por: Dorgham, Karim, et al.
Publicado: (2021)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Endobronchial ultrasound is feasible and safe to diagnose pulmonary embolism in non-transportable SARS-CoV-2 ARDS patients requiring extracorporeal lung support
por: Decavele, Maxens, et al.
Publicado: (2020)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

CD8(+)PD-L1(+)CXCR3(+) polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
por: Adam, Lucille, et al.
Publicado: (2021)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption
por: Lebreton, Guillaume, et al.
Publicado: (2021)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome
por: Mori, Izumi, et al.
Publicado: (2008)

Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report
por: Carrieri, Pietro, et al.
Publicado: (2013)

IgA dominates the early neutralizing antibody response to SARS-CoV-2
por: Sterlin, Delphine, et al.
Publicado: (2021)

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults
por: Barhoum, Petra, et al.
Publicado: (2022)

LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
por: Combadière, Behazine, et al.
Publicado: (2021)

Reply to “Key Points to Consider When Evaluating Andexxa for Formulary Addition”
por: Mahan, Charles E.
Publicado: (2020)

Response to: Cavagna et al The importance of considering cultural and environmental elements in an interventional model of care to fight hypertension in Africa
por: Otieno, Harun A., et al.
Publicado: (2021)

Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience
por: Decavèle, Maxens, et al.
Publicado: (2021)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
por: Rich, Sheldon
Publicado: (2003)

Delta beta thalassemia: a rare hemoglobin variant
por: Mansoori, Huma, et al.
Publicado: (2016)

Considering the design effect in cluster sampling
por: Alimohamadi, Yousef, et al.
Publicado: (2019)

Delicate Situation of Bipolar Disorder and Interferon Therapy
por: Aarab, Chadya, et al.
Publicado: (2018)

Plastic bronchitis: An unusual complication of acute chest syndrome in adult
por: Feray, Sarah, et al.
Publicado: (2017)

Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
por: Chauvin, Manon, et al.
Publicado: (2021)

Poor responders: Is it time to consider changing the nomenclature?
por: Chittawar, Priya Bhave, et al.
Publicado: (2012)

Athlete's heart and other entities to consider around
por: Martín, María, et al.
Publicado: (2020)

Stopping antiepileptic drugs – other factors to consider
Publicado: (2021)

Methodological notes, should be considered in research on mizaj
por: Farahani, Akram Moradi, et al.
Publicado: (2021)

The evaluation of left ventricular function for patients being considered for, or receiving Trastuzumab (Herceptin) therapy
por: Fox, K F
Publicado: (2006)

Idiopathic Granulomatous Mastitis as a Complication of Interferon-alpha Therapy
por: Shaaban, Hamid, et al.
Publicado: (2012)

Leech Infestation in the Vulvar Region: A Possibility to be Considered
por: Shahraki, Azar Danesh, et al.
Publicado: (2014)

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

Considering the Appropriateness of the Factor Analytic Operationalization of Allostatic Load
por: Crook, Zander, et al.
Publicado: (2017)

Complexities to consider when communicating risk of COVID-19
por: Skovdal, M., et al.
Publicado: (2020)

New certification requirement for autopsies: few things to consider
por: Hamza, Ameer
Publicado: (2021)

Reply to “Methodological notes, should be considered in research on Mizaj”
por: Aghanouri, Zahra, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f092r5ugqkp56919obg7rioi23